跳至主要内容
临床试验/NL-OMON20884
NL-OMON20884招募中不适用

Comparison of the effectiveness and tolerability of different doses of intravenous glucocorticoid for the treatment of moderately severe Graves' ophthalmopathy. EUGOGO study C

Prof. dr. W.M. WiersingaDept. of Endocrinology and MetabolismAcademic Medical CenterMeibergdreef 91105 AZ AmsterdamT: +31 20 566 6071F: +31 20 691 7682e-mail: w.m.wiersinga@amc.uva.nl0 个研究点目标入组 159 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
159

研究概览

简要总结

/A

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Graves' hyperthyroidism, euthyroid for at least two months by antithyroid drugs or surgery (at least 6 months if I131 is used;
  • 2. Moderately severe Graves' ophthalmopathy defined as having at least one of the following signs:
  • a. class 2b-c
  • b. mono-ocular duction <30 degrees
  • c. diplopia Gorman score grade a-c;
  • 3. Active Graves' ophthalmopathy (CAS 3 or higher out of 7);
  • 4. No past treatment of the ophthalmopathy except for local measures;
  • 5. Age 18-70 years.

排除标准

  • 1. CAS <3;
  • 2. Clinically relevant optic nerve involvement;
  • 3. General contra-indications to glucocorticoid infusions;
  • 4. Pregnancy;
  • 5. No informed consent;
  • 6. Viral hepatitis;
  • 7. Liver enzymes increased by a factor 2.

研究者

发起方
Prof. dr. W.M. WiersingaDept. of Endocrinology and MetabolismAcademic Medical CenterMeibergdreef 91105 AZ AmsterdamT: +31 20 566 6071F: +31 20 691 7682e-mail: w.m.wiersinga@amc.uva.nl

相似试验